Acquired by Everest Clinical Research, a Portfolio Company of Arlington Capital Partners
Headquartered in Somerset, New Jersey, Brightech International (“Brightech” or “BTI”) is a global clinical research organization (“CRO”) with significant operations in both the United States and Taiwan. Brightech specializes in complex, value-added biostatistics, programming and clinical data management services. With management’s 160+ years of combined experience, Brightech’s solutions have assisted more than 100 leading pharmaceutical and biotechnology companies. Since inception, Brightech has completed more than 400 projects, serving clients in North America, Europe, and Asia.